Equity Overview
Price & Market Data
Price: $0.0₃2
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $55
Daily Volume: 0
Performance Metrics
1 Week: 100.0%
1 Month: 100.0%
3 Months: 100.0%
6 Months: 100.0%
1 Year: 100.0%
YTD: 100.0%
Details
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.